drugset / Trial / NCT01111669

Intravenous Tranexamic Acid and Intraoperative Visualization During Functional Endoscopic Sinus Surgery

NCT01111669 ↗

Completed 28 enrolled University of Alberta
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Functional endoscopic sinus surgery (FESS) is an effective treatment of sinus disease. FESS is carried out using cameras to view the surgical field. Bleeding during the surgery can lead to poor surgical field visualization. Poor visualization has been associated with worse surgical outcomes. Tranexamic acid is a safe and effective agent used to achieve hemostasis during operative procedures. The current study is a randomized controlled trial in patients undergoing FESS to compare the effects of tranexamic acid versus placebo and the effects on surgical field visualization and adverse events.

Timeline

Start
2009-08
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1 mg/kg Intravenous